Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies

D Vanauberg, C Schulz, T Lefebvre - Oncogenesis, 2023 - nature.com
An accelerated de novo lipogenesis (DNL) flux is a common characteristic of cancer cells
required to sustain a high proliferation rate. The DNL enzyme fatty acid synthase (FASN) is …

Anticancer properties of medicinal plants and their bioactive compounds against breast cancer: a review on recent investigations

MI Khan, A Bouyahya, NEL Hachlafi, NE Menyiy… - … Science and Pollution …, 2022 - Springer
Breast cancer (BC) is one of the most common and recurring diseases and the second
leading cause of death in women. Despite prevention, diagnostics, and therapeutic options …

Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects

Y Hussain, L Islam, H Khan, R Filosa… - Phytotherapy …, 2021 - Wiley Online Library
The efficacy of chemotherapy in cancer therapy is limited due to resistance, treatment
selectivity, and severe adverse effects. Immunotherapy, chemotherapy, targeted therapy …

[HTML][HTML] Pharmacological mechanisms and clinical applications of curcumin: update

M Hao, Y Chu, J Lei, Z Yao, P Wang, Z Chen… - Aging and …, 2023 - ncbi.nlm.nih.gov
Curcumin, a well-known hydrophobic polyphenol extracted from the rhizomes of turmeric
(Curcuma longa L.), has attracted great interest in the last ten years due to its multiple …

Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer

R Farghadani, R Naidu - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer remains the most commonly diagnosed cancer and the
leading cause of cancer death among females worldwide. It is a highly heterogeneous …

Curcumin: the spicy modulator of breast carcinogenesis

U Banik, S Parasuraman, AK Adhikary… - Journal of Experimental & …, 2017 - Springer
Worldwide breast cancer is the most common cancer in women. For many years clinicians
and the researchers are examining and exploring various therapeutic modalities for breast …

Molecular targets of curcumin in breast cancer

X Song, M Zhang, E Dai, Y Luo - Molecular Medicine …, 2019 - spandidos-publications.com
Abstract Curcumin (diferuloylmethane), an orange‑yellow component of turmeric or curry
powder, is a polyphenol natural product isolated from the rhizome of Curcuma longa. For …

Antitumoral activities of curcumin and recent advances to improve its oral bioavailability

MC Nocito, A De Luca, F Prestia, P Avena, D La Padula… - Biomedicines, 2021 - mdpi.com
Curcumin, a main bioactive component of the Curcuma longa L. rhizome, is a phenolic
compound that exerts a wide range of beneficial effects, acting as an antimicrobial …

The “Yin and Yang” of natural compounds in anticancer therapy of triple-negative breast cancers

E Varghese, SM Samuel, M Abotaleb, S Cheema… - Cancers, 2018 - mdpi.com
Among the different types of breast cancers, triple-negative breast cancers (TNBCs) are
highly aggressive, do not respond to conventional hormonal/human epidermal growth factor …

Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors

TS Angeles, RL Hudkins - Expert opinion on drug discovery, 2016 - Taylor & Francis
Introduction: Elevated lipogenesis has been associated with a variety of diseases including
obesity, cancer and nonalcoholic fatty liver disease (NAFLD). Fatty acid synthase (FASN) …